Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Price:
3.71
USD
-7.94%
Market Closed
Market Cap:
$154.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
ORMP Price Forecast
Based on 3 analysts
Based on 3 analysts
+92% Upside
from
$3.71
today
Oramed Pharmaceuticals Inc (ORMP)’s 12-month stock price forecast through November 2027 has a consensus target of $7.14, implying 92% upside. The forecast is based on price targets from 3 Wall Street analysts.
ORMP Analyst Rating
Based on 1 analyst
Based on 1 analyst
The analyst rating for ORMP is Hold.
Oramed Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ORMP's stock price target?
Price Target
7.14
USD
7.14
USD
According to Wall Street analysts, the average 1-year price target for ORMP is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.
What is the Pre-Tax Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
236%
236%
The compound annual growth rate for Pre-Tax Income over the next 1 year is 236%.
What is the Net Income forecast for Oramed Pharmaceuticals Inc?
Projected CAGR
200%
200%
The compound annual growth rate for Net Income over the next 1 year is 200%.
